The intersection of drug delivery systems and nanotechnology represents a revolutionary leap in the field of medicine, offering unprecedented precision and efficacy in therapeutic interventions. Nanotechnology has propelled drug delivery into a realm where nanoscale materials serve as carriers for pharmaceutical agents, optimizing their pharmacokinetics and targeting. Nanoparticles, liposomes, and micelles are among the versatile nanocarriers engineered to encapsulate drugs, providing controlled release mechanisms that enhance drug bioavailability. Nanotechnology-enabled drug delivery systems address the limitations of traditional approaches by offering targeted delivery to specific cells or tissues. These nanocarriers, often designed to respond to physiological cues, navigate biological barriers and release therapeutic payloads with remarkable precision. This targeted approach minimizes systemic side effects, a critical advancement in improving patient outcomes. In cancer therapy, nanotechnology has revolutionized drug delivery with nanocarriers designed to selectively accumulate in tumor tissues, delivering chemotherapy directly to cancer cells while sparing healthy tissues. Additionally, nanotechnology facilitates the design of stimuli-responsive drug delivery systems, releasing medications in response to specific conditions within the body, such as pH or temperature changes. The advent of nanotechnology in drug delivery has also spurred innovations in personalized medicine. Nanocarriers can be tailored to accommodate diverse therapeutic agents, enabling the development of patient-specific treatment regimens. Implantable devices and nanosensors further contribute to this personalized approach, continuously monitoring and adapting drug delivery based on individual patient responses. Challenges such as biocompatibility, long-term stability, and regulatory considerations persist but ongoing research in nanotechnology continues to address these hurdles. As nanotechnology continues to evolve, it holds the promise of transforming drug delivery into a highly precise, patient-centric, and effective therapeutic modality, shaping the future of healthcare with innovations that redefine the boundaries of medical treatment.
Title : Circumventing challenges in developing CVD graphene coating on mild steel: A disruptive approach to remarkable/durable corrosion resistance
Raman Singh, Monash University-Clayton Campus, Australia
Title : Highlighting recent advancements in electromagnetic field subwavelength tailoring using nanoparticle resonant light scattering and related topics
Michael I Tribelsky, Moscow State University, Russian Federation
Title : The impact of nanomedicine: 30,000 orthopedic nano implants with no failures and still counting
Thomas J Webster, Hebei University of Technology, United States
Title : Logistic-modified mathematical model for tumor growth treated with nanosized cargo delivery system
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Current and future of red and black phosphorus nanomaterials
Hai Feng Ji, Drexel University, United States
Title : Azodye photoaligned nanolayers for liquid crystal: New trends
Vladimir G Chigrinov, Hong Kong University of Science and Technology, Hong Kong
Title : Atomistic simulation of chemical ordering phenomena in nanostructured intermetallics
Rafal Kozubski, Jagiellonian University in Krakow, Poland
Title : The enhanced cytotoxic effect of curcumin on leukemic stem cells via CD123-targeted nanoparticles
Wariya Nirachonkul, Chiang Mai University, Thailand
Title : Efficiency of nanoparticles (Micromage-B) in the complex treatment of multiple sclerosis
Andrey Belousov, Kharkiv National Medical University, Ukraine
Title : Innovative method of nanotechnology application in the complex treatment of multiple sclerosis
Andrey Belousov, Kharkiv National Medical University, Ukraine